Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
55.5M
-
Shares change
-
+3.01M
-
Total reported value, excl. options
-
$689M
-
Value change
-
+$37.2M
-
Put/Call ratio
-
0.61
-
Number of buys
-
66
-
Number of sells
-
-36
-
Price
-
$12.41
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2020
139 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2020.
Gossamer Bio, Inc. - Common Stock (GOSS) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5M shares
of 227M outstanding shares and own 24.43% of the company stock.
Largest 10 shareholders include HILLHOUSE CAPITAL ADVISORS, LTD. (7.42M shares), VANGUARD GROUP INC (4.71M shares), Capital International Investors (4.64M shares), BlackRock Inc. (4.64M shares), Omega Fund Management, LLC (3.32M shares), BOXER CAPITAL, LLC (2.56M shares), Artal Group S.A. (2.36M shares), ALLIANCEBERNSTEIN L.P. (2.31M shares), STATE STREET CORP (2.15M shares), and FEDERATED HERMES, INC. (2.02M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.